Alex Rabiee
Corporate Officer/Principal bei PROVENTION BIO, INC.
Ursprung des Netzwerks ersten Grades von Alex Rabiee
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 31 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alex Rabiee
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Investment Banks/Brokers | Founder Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Sales & Marketing | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
| ENDEAVOR IP INC | Miscellaneous Commercial Services | Chief Executive Officer | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Michigan State University | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Doctorate Degree | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal Founder | |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | General Counsel Corporate Officer/Principal | |
ICAP Patent Brokerage LLC
 ICAP Patent Brokerage LLC Real Estate DevelopmentFinance ICAP Patent Brokerage LLC provides intellectual property brokerage, live patent auction, and sealed-bid patent auction services. It operates a live auctioning platform for the buyers and sellers of patents and other intellectual property assets. The company is headquartered in New York, NY. | Real Estate Development | Corporate Officer/Principal | |
| Stanford University School of Medicine | College/University | Graduate Degree | |
| Harvard Law School | College/University | Graduate Degree | |
| George Washington University Law School | College/University | Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
| Stony Brook University School of Medicine | College/University | Doctorate Degree | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Biotechnology | Director/Board Member | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
Celimmune LLC
 Celimmune LLC Hospital/Nursing ManagementHealth Services Celimmune LLC is an American company that is not described in the provided metadata. Therefore, no summary can be provided. | Hospital/Nursing Management | Founder Chief Executive Officer | |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Miscellaneous Commercial Services | Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Biotechnology | Founder | |
| Alcedo Capital, Inc. | Founder | ||
| JDRF New England Chapter | President | ||
| New York University School of Medicine | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 48 |
| Niederlande | 3 |
| Spanien | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 4 |
Operativ
| Director/Board Member | 71 |
| Corporate Officer/Principal | 63 |
| Independent Dir/Board Member | 25 |
| Undergraduate Degree | 20 |
| Chief Executive Officer | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nancy Wysenski | 20 |
| Anthony DiGiandomenico | 14 |
| Wayne Pisano | 14 |
| Rita Jain | 14 |
| Jeffrey Bluestone | 14 |
| Ashleigh Palmer | 13 |
| Jan Hillson | 13 |
| Benedict Osorio | 12 |
| Sean N. Doherty | 12 |
| Francisco Leon | 11 |
| Cameron Gray | 11 |
| Avery Catlin | 11 |
| Eleanor Ramos | 11 |
| Andrew Drechsler | 10 |
| John Jenkins | 8 |
- Börse
- Insiders
- Alex Rabiee
- Unternehmensverbindungen
